147 related articles for article (PubMed ID: 30031678)
1. Extracapsular breast implant rupture mimicking local cancer recurrence on
Domínguez ML; Salvat C; F-Llana B; Vigil C; Suárez JP; González FM
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):392-394. PubMed ID: 30031678
[No Abstract] [Full Text] [Related]
2. F-18 FDG positron emission tomographic imaging in a case of ruptured breast implant: inflammation or recurrent tumor?
Hurwitz R
Clin Nucl Med; 2003 Sep; 28(9):755-6. PubMed ID: 12972998
[TBL] [Abstract][Full Text] [Related]
3. Breast implant foreign body reaction mimicking breast cancer recurrence on FDG PET/CT.
Ulaner GA; D'Andrea G; Cody HS
Clin Nucl Med; 2013 Jun; 38(6):480-1. PubMed ID: 23640240
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
Xiao Y; Wang L; Jiang X; She W; He L; Hu G
Nucl Med Commun; 2016 Nov; 37(11):1180-8. PubMed ID: 27428888
[TBL] [Abstract][Full Text] [Related]
5. [18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy.
Hildebrandt MG; Gerke O; Baun C; Falch K; Hansen JA; Farahani ZA; Petersen H; Larsen LB; Duvnjak S; Buskevica I; Bektas S; Søe K; Jylling AM; Ewertz M; Alavi A; Høilund-Carlsen PF
J Clin Oncol; 2016 Jun; 34(16):1889-97. PubMed ID: 27001573
[TBL] [Abstract][Full Text] [Related]
6.
Palot Manzil FF; Bhambhvani PG
J Nucl Med Technol; 2018 Dec; 46(4):394-395. PubMed ID: 30076249
[No Abstract] [Full Text] [Related]
7. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG-PET/CT in implant-associated anaplastic large cell lymphoma of the breast.
Acevedo-Báñez I; García-Gomez FJ; Jiménez-Granero P; Carrillo-Cruz E; Perez-Lopez O; Borrego-Dorado I
Br J Haematol; 2015 Apr; 169(1):1. PubMed ID: 25521839
[No Abstract] [Full Text] [Related]
10. Usefulness of CA125 and its kinetic parameters and positron emission tomography/computed tomography (PET/CT) with fluorodeoxyglucose ([
Palomar Muñoz A; Cordero García JM; Talavera Rubio P; García Vicente AM; González García B; Bellón Guardia ME; Soriano Castrejón Á; Aranda Aguilar E
Med Clin (Barc); 2018 Aug; 151(3):97-102. PubMed ID: 29276012
[TBL] [Abstract][Full Text] [Related]
11. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
12. Fluorodeoxyglucose positron emission tomography/computed tomography findings after percutaneous cryoablation of early breast cancer.
Adachi T; Machida Y; Fukuma E; Tateishi U
Cancer Imaging; 2020 Jul; 20(1):49. PubMed ID: 32678029
[TBL] [Abstract][Full Text] [Related]
13. Costosternal chondrodynia simulating recurrent breast cancer unveiled by FDG PET.
Mathew AS; El-Haddad G; Lilien DL; Takalkar AM
Clin Nucl Med; 2008 May; 33(5):330-2. PubMed ID: 18431146
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of SUV
Diao W; Tian F; Jia Z
Eur J Radiol; 2018 Aug; 105():1-7. PubMed ID: 30017264
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of recurrent and metastatic disease using f-18 fluorodeoxyglucose-positron emission tomography in breast cancer.
Eubank WB
Radiol Clin North Am; 2007 Jul; 45(4):659-67, vi. PubMed ID: 17706530
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of (18)F-FDG PET/CT for axillary lymph node staging in patients with breast cancer.
Kitajima K; Fukushima K; Miyoshi Y; Katsuura T; Igarashi Y; Kawanaka Y; Mouri M; Maruyama K; Yamano T; Doi H; Yamakado K; Hirota S; Hirota S
Jpn J Radiol; 2016 Mar; 34(3):220-8. PubMed ID: 26715510
[TBL] [Abstract][Full Text] [Related]
18. Prediction of local relapse and distant metastasis in patients with definitive chemoradiotherapy-treated cervical cancer by deep learning from [
Shen WC; Chen SW; Wu KC; Hsieh TC; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yen KY; Kao CH
Eur Radiol; 2019 Dec; 29(12):6741-6749. PubMed ID: 31134366
[TBL] [Abstract][Full Text] [Related]
19. FDG-PET/CT in the diagnosis of recurrent breast cancer.
Murakami R; Kumita S; Yoshida T; Ishihara K; Kiriyama T; Hakozaki K; Yanagihara K; Iida S; Tsuchiya S
Acta Radiol; 2012 Feb; 53(1):12-6. PubMed ID: 22067206
[TBL] [Abstract][Full Text] [Related]
20. Lung Cancer Recurrence:
Kandathil A; Sibley RC; Subramaniam RM
AJR Am J Roentgenol; 2019 Nov; 213(5):1136-1144. PubMed ID: 31361525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
